Cardiac ultrasound uses reflected sound waves (echos) to create images of anatomy inside the body. Echocardiograms are the primary cardiac imaging modality used to assess the heart and diagnose or track cardiac issues. Echo is the gold standard imaging modality to assess the heart, particularly with calculating left ventricular ejection fraction (LVEF), which is a measure of cardiac output. In addition to noninvasive standard transthoracic echo (TTE), invasive transesophgeal echo (TEE) is also used when clearer, more detailed imaging of the heart is needed. Both 3D and 4D echo echo systems are rapidly gaining wider adoption and enable new types of assessments, especially in the structural heart space and in transcatheter procedural guidance. Find news on general ultrasound imaging.

Luc Mertens, MD, section head of echocardiography at The Hospital for Sick Children in Toronto, explains application of ultrafast ultrasound and blood speckle imaging in echocardiography

Vector flow and blood speckle echocardiography imaging may unveil new clinical insights

Luc Mertens, MD, Hospital for Sick Children, Toronto, explains research and potential uses for ultrafast echo imaging.

February 20, 2024
Staff at the new Fetal Cardiac Clinic at the Heart Institute at Children's Hospital Los Angeles. From left, Director of the Heart Institute David Romberger, RN, MSN, CCRN; attending physician Shuo Wang, MD; Executive Director of the Heart Institute Jennifer Klunder, MHA; Director of the Fetal Cardiac Clinic Jodie Votava-Smith, MD; Chief of the Division of Cardiology and Co-director of the Heart Institute Paul F. Kantor, MBBCh, MSc, FRCPC; and congenital cardiac surgeon Luke Wiggins, MD.

Children’s Hospital Los Angeles unveils new fetal cardiac clinic

Clinic for expectant mothers designed to better diagnose and treat congenital heart defects and heart diseases before birth. 

February 20, 2024
AI cardiology heart artificial intelligence deep learning

AI could be a game-changer for TAVR, but cardiologists remain ‘irreplaceable’

The rise of TAVR as a go-to treatment option for many AS patients has been one of the biggest stories in cardiology for several years now. How will advanced AI models impact this trend going forward? 

February 12, 2024
Video interview with Marielle Scherrer-Crosbie, MD, Hospital of the University of Pennsylvania, who explains details of creating a cardio-oncology program, whoi should be involved and the role of cardiac imaging.

Key things to remember when creating a cardio-oncology program

Marielle Scherrer-Crosbie, MD, explains what is needed to create a cardio-oncology program, and the role played by cardiac imagers.

February 12, 2024
Marielle Scherrer-Crosbie, MD, Hospital of the University of Pennsylvania, discusses the latest trends in cardiac strain echo.

Interest in strain echo imaging is rising, but hurdles remain

Marielle Scherrer-Crosbie, MD, told Cardiovascular Business that the current lack of reimbursement for strain echocardiography has been a challenge for care teams. 

February 9, 2024
transthoracic echocardiogram images from 2024 ASE guidelines

American Society of Echocardiography shares updated expert recommendations on pediatric, neonatal echo

These new guidelines provide a fresh look at topics ASE has not addressed with official society recommendations in many years. 

February 6, 2024
Philips received U.S. Food and Drug Administration (FDA) clearance for a compact transesophageal echocardiography (TEE) ultrasound transducer. The X11-4t Mini 3D TEE transducer was designed to improve image quality when evaluating certain patient populations, including pediatric patients and adults who present with a heightened risk of complications.

FDA clears smaller 3D TEE transducer for imaging children, high-risk adult patients

The newly approved device is much smaller than previous offerings, helping operators capture 3D images during structural heart evaluations. 

January 31, 2024
Jeremy Slivnick, MD, presents at the American Society of Echocardiography (ASE) 2023 meeting on how artificial intelligence (AI) can help make echocardiography better able to detect subtle signs of early cardiac amyloid disease when it is easier to treat with better outcomes. ssistant professor of medicine and an advanced cardiac imager at the University of Chicago.

AI models for cardiac amyloidosis could make a world of difference

Jeremy Slivnick, MD, spoke with Cardiovascular Business about AI's potential to transform how cardiac amyloidosis is diagnosed and treated. 

January 30, 2024

Around the web

The Lower Costs, More Transparency Act requires radiologists to publicly list prices for certain "shoppable" services.

Renee Bullock-Palmer, MD, director, non-invasive cardiac imaging, at the Deborah Heart and Lung Center, explains CT calcium scoring can determine if a patient needs to take aspirin and statins for prevention of coronary disease.

Trimed Popup
Trimed Popup